DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20150176

Effect of glycemic status on peripheral nerve conduction in lower limbs in type 2 diabetes mellitus patients

Pranali P. Sonawane, Swati H. Shah, Swati H. Shah, Savita M. Vaidya, Savita M. Vaidya, Pradeep S. Nahar, Pradeep S. Nahar, Anupam S. Khare, Anupam S. Khare, Kiran H. Buge, Kiran H. Buge

Abstract


Background: Diabetes mellitus (DM) is one of the most common chronic diseases globally. Diabetic neuropathy is the most common & troublesome complication. But exact pathogenesis is not yet known. Comparatively there are few studies showing relation between glycemic status & diabetic neuropathy. Hence present study was conducted, which was aimed to assess the same in lower limbs in type 2 DM. 

Methods: 60 type 2 diabetes mellitus male patients were selected from diabetic OPD. 30 were having glycated hemoglobin (HbA1c) 6%-9% (group B), 30 were having HbA1c > 9% (group C). They were compared with age and sex matched 30 normal healthy controls (group A). Conduction velocity and amplitude of bilateral sural sensory nerve action potential (SNAP) and peroneal compound muscle action potential (CMAP) were recorded. Glycated hemoglobin was measured using ion exchange resin method.

Results: Group B and group C had significantly lesser means of conduction velocity and amplitude of sural
SNAP (p<0.001) and peroneal CMAP (p<0.05) as compared to group A. Hb A1c had statistically significant
negative correlation with conduction velocity and amplitude of sural SNAP (p<0.001) as well as peroneal CMAP (p<0.001).

Conclusions: This study shows that diabetic patients with higher blood glucose levels are at increased risk of diabetic neuropathy. Diabetic neuropathy in lower limbs worsens with increasing blood glucose levels. Hence stringent action has to be taken at an early stage to control blood glucose levels. Also, patients should be encouraged for regular follow up and strict glycemic control.

 


Keywords


Type 2 diabetes mellitus, Diabetic neuropathy, Nerve conduction study, HbA1c

Full Text:

PDF

References


International Diabetes Federation. Diabetes atlas. 6th ed. The global burden. 2013 (updated on 2014). Available from: http://www.idf.org/diabetesatlas/ 6e/the-global-burden. Accessed 15 Mar 2015.

World Health Organization. Mediacentre, factsheets. Diabetes. 2012. (Updated on January 2015). Available from: http://www.who.int/ mediacentre/factsheets/fs312/en/index.html. Accessed 15 Mar 2015.

Ugoya SO, Ugoya TA, Puepet FH, Agaba EI, Ogunniyi AO. Risk determinants of diabetic peripheral neuropathy in Jos, North-Central Nigeria. J Chin Clin Med. 2008; 3(5): 285-91.

Thomas PK, Eliasson SG. Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambart EH, Bunge R, editors. Peripheral neuropathy. 2nd ed. Philadelphia: W. B. Saunders Co.; 1984: 1773-1810.

Nathan D. Long-term complications of diabetes mellitus. N Engl J Med 1993;328(23):1676-85.

Dyck PJ, O’ Brien PC. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 1989;12(9):649-52.

Nathan DM, Singer DE, Hurxthal K, Goodson JD. The Clinical Information Value of The Glycosylated Haemoglobin Assay. N Eng J Med 1984;310:341-6.

Misra UK, Kalita J. Nerve conduction study. In: Clinical Neuophysiology. 2nd ed. New Delhi, India: Elsevier; 2006: 21-128.

Preston DC, Shapiro BE. Basic nerve conduction studies. In: Electromyography and neuromuscular disorders. 2nd ed. Philadelphia, USA: Elsevier; 2005: 25-45.

Preston DC, Shapiro BE. Routine lower extremity nerve conduction techniques In: Electromyography and neuromuscular disorders. 2nd ed. Philadelphia, USA: Elsevier; 2005: 145-60.

Greene DA, Winegrad AI. In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural compartments of peripheral nerve. Diabetes 1979;28 (10):878-87.

Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998;21(10):1749-52.

Brazier MAB. The emergence of electrophysiology as an aid to neurology. In: Aminoff MJ, editor. Electrodiagnosis in clinical neurology. 6th ed. China: Elsevier; 2012: 3-14.

Oh SJ. Nerve conduction in polyneuropathies. In: Clinical electromyography: Nerve conduction studies. 3rd ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2003. 695-802.

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333(2):89-94.

Kimura J: Electrodiagnosis in Disease of Nerve and Muscle: Principles and Practice, 3rd ed. New York:Oxford University Press, 2004.39 – 494.

Dutta A, Naorem S, Singh P, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diab Dev Ctries 2005; 25: 30-33.

Ugoya SO, Ugoya TA, Puepet FH, Agaba EI, Ogunniyi AO. Risk determinants of diabetic peripheral neuropathy in Jos, North-Central Nigeria. J Chin Clin Med. 2008;3(5):285-91.

Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications 1997;11(1):27-34.

Perkins BA, Greene DA, Bril V. Glycemic Control Is Related to the Morphological Severity of Diabetic Sensorimotor Polyneuropathy. Diabetes Care 2001;24:748–52.

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333(2): 89-94.

Bagai K, Wilson JR, Khanna M, Song Y, Wang L, Fisher MA. Electrophysiological patterns of diabetic polyneuropathy. Electromyogr Clin Neurophysiol 2008;48(3-4):139-45.

Said G, Slama G, Selva J. Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain 1983;106(4):791-807.

Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001;24(9):1229-31.

Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF. Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 1977;26(6):546-50.

King RH (2001). The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol 2001;54(6):400-8.

Vlassara H, Brownlee M, Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983;32(7):670-4.

Vlassara H, Brownlee M, Cerami A. Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes. 1885;34(6):553-7.

Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003;52(1):165-71.

Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol 2006;2(11):620-8.